Fundz

Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer

PRIVATESep 02, 2025

Position

Chief Scientific Officer

Company

Aera Therapeutics

Bill Querbes
bill.querbes@aeratx.com
BostonBiotechnologyHealth CareTherapeutics

Description

Aera Therapeutics has announced the appointment of Dr Bill Querbes as Chief Scientific Officer. Dr Querbes brings over 20 years of experience in drug development and a strong background in genetic medicines.

Quick answer

Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer (September 2, 2025). Aera Therapeutics is based in Boston, Massachusetts, United States.

Who is the new Chief Scientific Officer at Aera Therapeutics?
Aera Therapeutics named Bill Querbes Chief Scientific Officer, announced September 2, 2025.
What did Aera Therapeutics announce on September 2, 2025?
Aera Therapeutics has announced the appointment of Dr Bill Querbes as Chief Scientific Officer. Dr Querbes brings over 20 years of experience in drug development and a strong background in genetic medicines.
What does Aera Therapeutics do?
Aera Therapeutics is a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines.
Where is Aera Therapeutics based?
Aera Therapeutics is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Hemab Therapeutics (September 2, 2025), Amorphical (September 2, 2025), Pharming Group (September 2, 2025) and DeepQure (September 3, 2025) also announced leadership changes within 45 days of Aera Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aera Therapeutics, and when

A new leader at Aera Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aera Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aera Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aera Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aera Therapeutics

Location

Boston, Massachusetts, United States

About

Aera Therapeutics is a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines. Aera has two proprietary delivery platforms – lipid nanoparticles (LNPs) and protein nanoparticles (PNPs) – that are being developed to enable next-generation genetic medicines across a range of therapeutic modalities and disease areas. Aera’s vision is to expand the reach of genetic medicines to different tissues and applications, in order to benefit more patients across more disease areas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aera Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Paul
Likely contact at this company
••••••••@••••••••

See Paul's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aera Therapeutics's next move

Learn about Strategic plan

Aera Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.